Rating History for Inmed Pharmaceuticals (INM) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for INM
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/16/2022 Scott Henry Upgrade Buy
(Neutral)		 0.80
(6.00)		 0.83
(1.50)		 80.72% Details